Michael Gurevich

3.4k citations
108 papers · 2.3k indexed · 1 hit paper · h-index 27
Topics
Multiple Sclerosis Research Studies (41 papers)Cytokine Signaling Pathways and Interactions (19 papers)SARS-CoV-2 and COVID-19 Research (13 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONENeurology

In The Last Decade

Michael Gurevich

102 papers receiving 2.3k citations

Hit Papers

Humoral immune response to COVID-19 mRNA vaccine in patie...2021202620222024202150100150200

Peers

Michael Gurevich
Comparison fields: 5 of 124
  • Pathology and Forensic Medicine 976
  • Immunology 615
  • Molecular Biology 554
  • Infectious Diseases 522
  • Neurology 426
Replace Michael C. Levin with:
Michael C. Levin United States
Sandra D’Alfonso Italy
H. Carton Belgium
Jill A. Hollenbach United States
Bruce F. Bebo United States
Lei Su China
Brendan McLean United Kingdom
Yoh Hidaka Japan
Jayne Ness United States
Marie‐Anne Bach France
Michael Gurevich relative to Michael C. Levin United States Michael C. Levin's profile →
Citations per field
00.5×7.5×
Michael C. Levin · 1×
Citations per year

Countries citing papers authored by Michael Gurevich

Since Specialization
Citations

This map shows the geographic impact of Michael Gurevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gurevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gurevich more than expected).

Fields of papers citing papers by Michael Gurevich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gurevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gurevich. The network helps show where Michael Gurevich may publish in the future.

Co-authorship network of co-authors of Michael Gurevich

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gurevich. A scholar is included among the top collaborators of Michael Gurevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gurevich. Michael Gurevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 3
4 2
5 26
6 12
7 49
8 13
9 23
10 8
11 1
12
Oculopharyngeal muscular dystrophy among Bulgarian Jews: a new cluster?
7
13 119
14 20
15 18
16 40
17 33
18 7
19 22
20 61

About Michael Gurevich

Michael Gurevich is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology, having authored 108 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (41 papers), Cytokine Signaling Pathways and Interactions (19 papers) and SARS-CoV-2 and COVID-19 Research (13 papers). The work is most often cited by research in Pathology and Forensic Medicine (976 citations), Immunology (615 citations) and Infectious Diseases (522 citations). Michael Gurevich has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Anat Achiron, Mathilda Mandel, David Magalashvili, Mark Dolev, Anna Feldman, Shay Menascu, Sapir Dreyer-Alster, Laurence S. Shore, Rina Falb and Naftali Kaminski. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026